Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Acceleron Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Acceleron Pharma Inc (XLRN-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for XLRN

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

30 Oct 2016 ValuEngine, Inc. 11 $25.00

ACCELERON PHARMA INC (XLRN=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

29 Oct 2016 Pechala's Reports 2 $25.00

Value Graph: ACCELERON PHARMA -- XLRN

28 Oct 2016 Ford Investor Services, Inc. 1 $12.00

Acceleron Pharma, Inc. (XLRN) - Financial Analysis Review

Acceleron Pharma, Inc. (XLRN) - Financial Analysis Review Summary Acceleron Pharma, Inc. (Acceleron Pharma) is a biopharmaceu...

14 Oct 2016 GlobalData 56 $300.00

Wright Investors Service Comprehensive Report for Acceleron Pharma Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

07 Oct 2016 Wright Reports 63 $75.00

XLRN.OQ - Event Transcript of Acceleron Pharma Inc conference call, Sep. 12, 2016 / 3:40PM ET

Edited Event Transcript of XLRN.OQ conference call, Sep. 12, 2016 / 3:40PM ET New York, Sep 12, 2016 (Thomson StreetEve...

12 Sep 2016 Thomson Reuters StreetEvents 10 $75.00

Acceleron Pharma, Inc. (XLRN) - Financial Analysis Review

Acceleron Pharma, Inc. (XLRN) - Financial Analysis Review Summary Acceleron Pharma, Inc. (Acceleron Pharma) is a biopharmaceu...

12 Sep 2016 GlobalData 49 $300.00

XLRN.OQ - Event Transcript of Acceleron Pharma Inc conference call, Aug. 04, 2016 / 8:00AM ET

Edited Event Transcript of XLRN.OQ conference call, Aug. 04, 2016 / 8:00AM ET Boston, Aug 4, 2016 (Thomson StreetEvents...

04 Aug 2016 Thomson Reuters StreetEvents 8 $75.00